Abstract
Immunoturbidimetric assays for measuring the apolipoproteins A1 and B using the Cobas Bio centrifugal analyser are described. The methods were specific, offered good sensitivity (less than 0.05 g/l) and intrabatch variability, with coefficients of variation between 2.4% and 3.5%, and were cost effective. Reference ranges were calculated for a group of civil servants, aged 35 to 55 years.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Heuck C. C., Schlierf G. Nephelometry of apolipoprotein B in human serum. Clin Chem. 1979 Feb;25(2):221–226. [PubMed] [Google Scholar]
- Noma A., Yokosuka T., Kitamura K. Plasma lipids and apolipoproteins as discriminators for presence and severity of angiographically defined coronary artery disease. Atherosclerosis. 1983 Oct;49(1):1–7. doi: 10.1016/0021-9150(83)90002-3. [DOI] [PubMed] [Google Scholar]
- Rosseneu M., Vercaemst R., Vinaimont N., Van Tornout P., Henderson L. O., Herbert P. N. Quantitative determination of human plasma apolipoprotein A-I by laser immunonephelometry. Clin Chem. 1981 Jun;27(6):856–859. [PubMed] [Google Scholar]
- Rosseneu M., Vinaimont N., Vercaemst R., Dekeersgieter W., Belpaire F. Standardization of immunoassays for the quantitation of plasma Apo B protein. Anal Biochem. 1981 Sep 1;116(1):204–210. doi: 10.1016/0003-2697(81)90345-6. [DOI] [PubMed] [Google Scholar]
- Van Stiphout W. A., Hofman A., Kruijssen H. A., Vermeeren R., Groot P. H. Is the ratio of apo B/apo A-I an early predictor of coronary atherosclerosis? Atherosclerosis. 1986 Nov;62(2):179–182. doi: 10.1016/0021-9150(86)90065-1. [DOI] [PubMed] [Google Scholar]